Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105). Issue 9 (31st July 2022) - Maruyama, Dai; Iida, Shinsuke; Machida, Ryunosuke; Kusumoto, Shigeru; Fukuhara, Noriko; Yamauchi, Nobuhiko; Miyazaki, Kana; Yoshimitsu, Makoto; Kuroda, Junya; Tsukamoto, Norifumi; Tsujimura, Hideki; Usuki, Kensuke; et al.